Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
Ark is already conducting studies with this new class of pain medication, leveraging its strong infrastructure, experienced staff, and extensive access to patient populations. With strong community ...
University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI ...